← Back to Search

American Lung Association (ALA) Lung Health Cohort

Kansas City, KS
N/A
Recruiting
Led By Ravi Kalhan, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group

Summary

The ALA-LHC is a longitudinal, multi-center cohort study that will enroll approximately 4,000 young adults between the ages of 25-35 who do not have severe lung disease. The overarching objective of the ALA-LHC is to establish a national cohort of young adults for the purpose of defining lung health and developing targets to intercept chronic lung disease at its earliest stages.

See full description
Eligible Conditions
  • Lung Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pre-bronchodilator measurement of Forced Expiratory Volume in one second (FEV1)
Pre-bronchodilator measurements of Forced Vital Capacity (FVC)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Closest Location:University of Kansas· Kansas City, KS

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,361 Previous Clinical Trials
15,156,480 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,980 Previous Clinical Trials
47,862,213 Total Patients Enrolled
American Lung AssociationOTHER
31 Previous Clinical Trials
6,953 Total Patients Enrolled
Stanford UniversityOTHER
2,522 Previous Clinical Trials
17,423,700 Total Patients Enrolled
Ravi Kalhan, MDPrincipal InvestigatorNorthwestern University
1 Previous Clinical Trials
3,193 Total Patients Enrolled
~1172 spots leftby Sep 2026